Anti-cancer effect of Cyclosporin A on oral squamous cell carcinoma cell line.
- Author:
Han Wook LIM
1
;
Kyung Wook KIM
Author Information
1. Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook Universiy, Korea. kkwoms@dku.edu
- Publication Type:Original Article
- Keywords:
Squamous cell carcinoma;
Anticancer agent;
Cyclosporin-A;
apoptosis;
mRNAs
- MeSH:
Apoptosis;
Carcinoma, Squamous Cell*;
Caspase 9;
Cell Cycle;
Cell Death;
Cell Line*;
Cyclosporine*;
Cytoplasm;
Electrophoresis;
Mitochondria;
Mortality;
Mouth Neoplasms;
Oxidoreductases;
Prognosis;
RNA;
RNA, Messenger;
Smoke;
Smoking;
Survival Rate
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2004;30(6):474-481
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Squamous cell carcinoma is the most prevalent oral cancer, which is characterized by its low survival rate, high malignancy, mortality with facial defects, and poor prognosis. Exact cause and pathogenesis of the squamous cell carcinoma is still unknown. Various routes including smoking, radiation, and viral infections predispose its genesis, and recent studies revealed that genetic defects which fail to prevent cancer proliferation play a role. Generally, a cancer develops from the decreased rate of apoptosis which is an active and voluntary cell death, and from the altered cell cycles. Anticancer effect can be obtained by recovering the apoptotic process, and by suppressing the cell cycles. Among the apoptosis related factors, bcl-2, caspase-9, and VDAC (voltage-dependent anion channel)are produced in mitochondria of the cell. Cyclosporin-A is known to induce apoptosis through its activation with VDAC. This study was to reveal the anticancer effect of Cyclosporin A to the oral squamous cell carcinoma. The inverted microscope was used to find alterations in the tissue, and sensitivity test to the anticancer cells was performed with MTT (Tetrazolium-based colorimetric) assay. Following cell line culture of primary and metastastic oral squamous cell carcinoma, electrophoresis was performed with extracted total RNA. Finally, semi-quantitative study was carried out through RT-PCR (Reverse Transcription-Polymerase Chain Reaction). The results of this study are as follows: 1. The inverted microscopic observation revealed a poorly defined cytoplasm at 2000ng.3000ng/ml, indistinct nucleus, and apoptosis. 2. The Growth of cancer cells was decreased at 1000ng/ml of cyclosporin-A. No cancer cell growth was observed at over 2000ng/ml concentration of cyclosporin-A, and at one week, growth of cancer cells was ceased. 3. The MTT assays were decreased as cyclosporin-A concentration was increased. This means that the activation of succinyl dehydrogenase in mitochondria was decreased following administration of cyclosporin A. 4. A result of RT-PCR showed that amount of mRNA of VDAC-2 was decreased half times at a cyclosporine-A concentration of 2000ng/ml. In bcl-2, amount of mRNA was significantly decreased 1/5 times at 2000ng/ml. caspase-9, however, showed slight increase compared to the control group. From the results obtained in this study, administration of cyclosporin-A to the cell lines of oral squamous cell carcinoma induced alterations in morphology and growth of the cells as its concentration increased. Since apoptosis related factors such as VDAS-2, bcl-2, and caspase-9 also showed distinct alterations on their mRNAs, further research on cyclosporin A as an anti-cancer agent will be feasible.
